首页> 外文会议>World congress on medical physics and biomedical engineering;International congress of the IUPESM >In vitro online postdilution hemodiafiltration: effect of various bicarbonate dialysis fluid concentrations on acid-base status
【24h】

In vitro online postdilution hemodiafiltration: effect of various bicarbonate dialysis fluid concentrations on acid-base status

机译:体外在线稀释后血液透析滤过:各种碳酸氢盐透析液浓度对酸碱状态的影响

获取原文

摘要

In hemodialysis, bicarbonate (HCO_3~1) balance c may be affected by the choice of HCO_3~1concentration in the dialysis fluid. In online postdilution hemodiafiltration (HDF), we studied the effect of three various HCO_3~1 dialysis fluid concentrations on HCO_3~1 transport across the hemodialyser membrane and on the final HCO_3~1 balance for the in vitro patient. Variation with time of HCO," patient concentration, and HCO_3~1 mass transfers (across the hemodialyser membrane and gained by the patient) were studied in six in vitro tests using c heparinized bovine blood. They were compared with theoretical HCO_3~1 concentrations calculated by a mathematical model using mass balance equation for the patient and a description of local mass transfer in the hemodialyser. In postdilution HDF, the HCO_3~1 mass transfer across the hemodialyser membranes becomes positive because HCO_3~1 is lost from blood to dialysis fluid by ultrafiltration. The gain of HCO," by the in vitro patient is only obtained with the amount of HCO_3~1 re-injected. Moreover it has been seen that depend- ing on the HCO," dialysis fluid concentration, HCO," plasma concentration kinetics are very different and that the HCO_3~1 dialysis fluid concentration determines the maximum plasma concentration. The representation of final HCO_3~1 plasma con- centration (Cpf) in function of the initial one (Cpi) can be seen as a tool to adapt the HCO_3~1 dialysis fluid concentration (Cdi). The data suggest the following empirical correlation for final HCO_3~1 plasma concentration: Cpf = 0.2Cpi + (Cdi - 6.4) Our single pool in vitro model seems to reproduce adequately the kinetics and mass transfer of HCO," with a small blood volume. It can be used to compare efficiencies of various HDF strategies (re-injection rate, HCO_3~1 dialysis fluid concentration).
机译:在血液透析中,碳酸氢盐(HCO_3〜1)的平衡c可能会受到透析液中HCO_3〜1浓度的选择的影响。在在线稀释后血液透析滤过(HDF)中,我们研究了三种不同的HCO_3〜1透析液浓度对跨血液透析膜的HCO_3〜1转运以及体外患者最终HCO_3〜1平衡的影响。 在六次使用肝素化牛血的体外试验中研究了HCO,患者浓度和HCO_3〜1传质(通过血液透析膜并由患者获得)的变化,并将其与理论HCO_3〜1浓度进行了比较通过使用针对患者的质量平衡方程的数学模型和血液透析仪中局部质量转移的描述。 在稀释后HDF中,由于血液中HCO_3〜1通过超滤从血液中流失到透析液中,因此HCO_3〜1在整个血液透析膜上的传质变得积极。仅通过重新注射HCO_3〜1即可获得体外患者的HCO增益。此外,还发现依赖于HCO的透析液浓度,HCO和血浆浓度动力学是有效的。 HCO_3〜1透析液的浓度决定了最大血浆浓度,两者之间的差异非常大,最终HCO_3〜1血浆浓度(Cpf)与初始血浆浓度(Cpi)的关系可以看作是适应HCO_3的工具〜1透析液浓度(Cdi)。数据表明最终HCO_3〜1血浆浓度具有以下经验相关性:Cpf = 0.2Cpi +(Cdi-6.4)我们的单池体外模型似乎可以充分再现动力学和传质HCO”,血量少。它可用于比较各种HDF策略(再注入率,HCO_3〜1透析液浓度)的效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号